 | Kappa variant is a variant of SARS-CoV-2, the virus that causes COVID-19. It is one of the three sublineages of Pango lineage B.1.617. The SARS-CoV-2... 20 KB (1,537 words) - 22:05, 3 November 2023 |
| Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are... 228 KB (20,969 words) - 03:47, 28 April 2024 |
| The Alpha variant (B.1.1.7) was a SARS-CoV-2 variant of concern. It was estimated to be 40–80% more transmissible than the wild-type SARS-CoV-2 (with most... 219 KB (18,220 words) - 23:46, 31 March 2024 |
| The Beta variant, (B.1.351), was a variant of SARS-CoV-2, the virus that causes COVID-19. One of several SARS-CoV-2 variants initially believed to be... 72 KB (6,070 words) - 06:39, 3 February 2024 |
| variant (B.1.617.2) was a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in India on 5 October 2020. The Delta variant was... 101 KB (10,984 words) - 22:09, 17 October 2023 |
| The Gamma variant (P.1) was one of the variants of SARS-CoV-2, the virus that causes COVID-19. This variant of SARS-CoV-2 has been named lineage P.1 and... 60 KB (4,943 words) - 18:26, 28 February 2024 |
| Omicron (B.1.1.529) is a variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South... 207 KB (23,819 words) - 16:45, 15 April 2024 |
 | Epsilon variant, also known as CAL.20C and referring to two PANGO lineages B.1.427 and B.1.429, is one of the variants of SARS-CoV-2, the virus that causes... 13 KB (980 words) - 11:10, 16 January 2024 |
| Theta variant, also known as lineage P.3, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. The variant was first identified in the... 13 KB (1,007 words) - 07:42, 3 February 2024 |
 | The Eta variant is a variant of SARS-CoV-2, the virus that causes COVID-19. The Eta variant or lineage B.1.525, also called VUI-21FEB-03 (previously VUI-202102/03)... 9 KB (521 words) - 21:49, 30 January 2024 |
 | 30, 2020, to May 5, 2023. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans. SARS‑CoV‑2 is a strain of the species... 122 KB (12,474 words) - 22:56, 12 April 2024 |
| Zeta variant, also known as lineage P.2, is a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in the state of Rio de Janeiro;... 4 KB (428 words) - 00:56, 13 October 2023 |
| mutations of SARS-CoV-2 Lambda variant plotted on a genome map of SARS-CoV-2 with a focus on the spike. First samples of the Lambda variant were detected... 14 KB (1,091 words) - 15:50, 23 March 2024 |
| The Mu variant, also known as lineage B.1.621 or VUI-21JUL-1, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected... 27 KB (2,258 words) - 22:09, 2 November 2023 |
| Iota variant, also known as lineage B.1.526, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected in New York City... 10 KB (618 words) - 08:20, 3 March 2024 |
Twitch Kappa effect, a sensory illusion relating to the human perception of time SARS-CoV-2 Kappa variant, one of the variants of SARS-CoV-2, the virus... 2 KB (280 words) - 12:02, 2 March 2024 |
| American mink and the European mink have shown high susceptibility to SARS-CoV-2 since the earliest stages of the COVID-19 pandemic, first in mink farms... 11 KB (1,175 words) - 22:20, 13 September 2023 |
variant... Haseltine, William. "An Indian SARS-CoV-2 Variant Lands In California. More Danger Ahead?". Forbes. Retrieved 20 April 2021. "SARS-CoV-2 variants... 10 KB (1,072 words) - 19:24, 23 August 2023 |
| showed that 40% of sampled white-tailed deer demonstrated evidence of SARS-CoV-2 antibodies, with the highest percentages in Michigan, at 67%, and Pennsylvania... 25 KB (2,543 words) - 21:03, 19 January 2024 |
| has an expanded host range compared to SARS-CoV-1 and MERS-CoV. SARS-CoV-2 (along with SARS-CoV-1 and MERS-CoV) are generalist viruses, not specifically... 41 KB (5,118 words) - 22:55, 21 April 2024 |
| Origin of COVID-19 (redirect from Origins of SARS-CoV-2) to the SARS-CoV-1 and MERS-CoV outbreaks, and consistent with other pandemics in human history. Available evidence suggests that the SARS-CoV-2 virus was... 116 KB (13,419 words) - 04:31, 1 April 2024 |
 | COVID-19 pandemic (redirect from SARS-CoV-2 outbreak) and is used for other variants. SARS-CoV-2 is a virus closely related to bat coronaviruses, pangolin coronaviruses, and SARS-CoV. The first known outbreak... 372 KB (32,320 words) - 14:17, 28 April 2024 |
 | disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019... 285 KB (32,672 words) - 14:17, 28 April 2024 |
| This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible... 171 KB (16,045 words) - 18:15, 30 March 2024 |
| Cluster 5 (redirect from COVID-19 variant Cluster 5) Serum Institut for a virus variant described by the institute in autumn 2020, in connection with investigations of SARS-CoV-2 infection among mink and humans... 34 KB (3,519 words) - 12:34, 10 April 2024 |
 | Transmission of COVID-19 (redirect from Asymptomatic transmission of SARS-CoV-2) "The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus". Journal of Travel Medicine. 28... 67 KB (7,104 words) - 19:10, 19 April 2024 |
| This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible... 23 KB (2,009 words) - 11:02, 23 April 2024 |
COVID-19 vaccine (redirect from Sars cov 2 vaccine) acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19). Prior to... 192 KB (21,930 words) - 19:29, 15 April 2024 |
| Novavax COVID-19 vaccine (redirect from SARS-CoV-2 rS (NVX-CoV2373)) different SARS-CoV-2s was 90.4% and efficacy against moderate-to-severe disease was 100%. Trials were conducted before the emergence of the SARS-CoV-2 Omicron... 65 KB (4,734 words) - 04:34, 31 March 2024 |
| (AD) patients are at an increased risk of morbidity and mortality from SARS-CoV-2, the virus that causes COVID-19. AD is the most common cause of dementia... 34 KB (3,555 words) - 03:09, 19 March 2024 |